
Rasem Mourad
Examiner (ID: 7274, Phone: (571)270-7770 , Office: P/2836 )
| Most Active Art Unit | 2836 |
| Art Unit(s) | 2836 |
| Total Applications | 617 |
| Issued Applications | 444 |
| Pending Applications | 46 |
| Abandoned Applications | 142 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8421315
[patent_doc_number] => 08277803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-02
[patent_title] => 'Cancerous disease modifying antibodies'
[patent_app_type] => utility
[patent_app_number] => 13/211090
[patent_app_country] => US
[patent_app_date] => 2011-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17407
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13211090
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/211090 | Cancerous disease modifying antibodies | Aug 15, 2011 | Issued |
Array
(
[id] => 7784629
[patent_doc_number] => 20120046185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => 'PANEL OF BIOMARKERS FOR OVARIAN CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/204566
[patent_app_country] => US
[patent_app_date] => 2011-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 15732
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20120046185.pdf
[firstpage_image] =>[orig_patent_app_number] => 13204566
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/204566 | PANEL OF BIOMARKERS FOR OVARIAN CANCER | Aug 4, 2011 | Abandoned |
Array
(
[id] => 7580811
[patent_doc_number] => 20110294694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'Methods for detecting, diagnosing and treating human renal cell carcinoma'
[patent_app_type] => utility
[patent_app_number] => 13/136588
[patent_app_country] => US
[patent_app_date] => 2011-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 13669
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20110294694.pdf
[firstpage_image] =>[orig_patent_app_number] => 13136588
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/136588 | Methods for detecting, diagnosing and treating human renal cell carcinoma | Aug 3, 2011 | Issued |
Array
(
[id] => 8829946
[patent_doc_number] => 20130130991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'USE OF A PEPTIDE ENHANCING THE ABILITY OF RADIATION THERAPY TO KILL CANCER CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/813702
[patent_app_country] => US
[patent_app_date] => 2011-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9230
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813702
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/813702 | USE OF A PEPTIDE ENHANCING THE ABILITY OF RADIATION THERAPY TO KILL CANCER CELLS | Jul 28, 2011 | |
Array
(
[id] => 8820983
[patent_doc_number] => 20130122027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'NEOEPITOPE DETECTION OF DISEASE USING PROTEIN ARRAYS'
[patent_app_type] => utility
[patent_app_number] => 13/811687
[patent_app_country] => US
[patent_app_date] => 2011-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 34836
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811687
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/811687 | NEOEPITOPE DETECTION OF DISEASE USING PROTEIN ARRAYS | Jul 24, 2011 | Abandoned |
Array
(
[id] => 8820983
[patent_doc_number] => 20130122027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'NEOEPITOPE DETECTION OF DISEASE USING PROTEIN ARRAYS'
[patent_app_type] => utility
[patent_app_number] => 13/811687
[patent_app_country] => US
[patent_app_date] => 2011-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 34836
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811687
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/811687 | NEOEPITOPE DETECTION OF DISEASE USING PROTEIN ARRAYS | Jul 24, 2011 | Abandoned |
Array
(
[id] => 12408609
[patent_doc_number] => 09969802
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-15
[patent_title] => Method for detecting malignant tumor cells
[patent_app_type] => utility
[patent_app_number] => 13/810377
[patent_app_country] => US
[patent_app_date] => 2011-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 8677
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810377
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/810377 | Method for detecting malignant tumor cells | Jul 14, 2011 | Issued |
Array
(
[id] => 10549511
[patent_doc_number] => 09274130
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-01
[patent_title] => 'Prevention and treatment of pain using antibodies to lysophosphatidic acid'
[patent_app_type] => utility
[patent_app_number] => 13/182644
[patent_app_country] => US
[patent_app_date] => 2011-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 28194
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13182644
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/182644 | Prevention and treatment of pain using antibodies to lysophosphatidic acid | Jul 13, 2011 | Issued |
Array
(
[id] => 9529954
[patent_doc_number] => 08753822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-17
[patent_title] => 'Neoepitope detection of disease using protein arrays'
[patent_app_type] => utility
[patent_app_number] => 13/163951
[patent_app_country] => US
[patent_app_date] => 2011-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 34
[patent_no_of_words] => 32905
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13163951
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/163951 | Neoepitope detection of disease using protein arrays | Jun 19, 2011 | Issued |
Array
(
[id] => 7754461
[patent_doc_number] => 20120027684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'CANCER THERAPY BASED ON TUMOR ASSOCIATED ANTIGENS DERIVED FROM CYCLIN D1'
[patent_app_type] => utility
[patent_app_number] => 13/150785
[patent_app_country] => US
[patent_app_date] => 2011-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9740
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20120027684.pdf
[firstpage_image] =>[orig_patent_app_number] => 13150785
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/150785 | Cancer therapy based on tumor associated antigens derived from cyclin D1 | May 31, 2011 | Issued |
Array
(
[id] => 8421936
[patent_doc_number] => 08278424
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-02
[patent_title] => 'Antibodies that bind to PSCA proteins for diagnosis of cancer'
[patent_app_type] => utility
[patent_app_number] => 13/094730
[patent_app_country] => US
[patent_app_date] => 2011-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 100
[patent_no_of_words] => 78107
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13094730
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/094730 | Antibodies that bind to PSCA proteins for diagnosis of cancer | Apr 25, 2011 | Issued |
Array
(
[id] => 8648827
[patent_doc_number] => 20130034557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-07
[patent_title] => 'Cancer-Related Glycopeptide Epitopes, Antibodies And Methods Of Use'
[patent_app_type] => utility
[patent_app_number] => 13/641610
[patent_app_country] => US
[patent_app_date] => 2011-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7729
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641610
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/641610 | Cancer-related glycopeptide epitopes, antibodies and methods of use | Apr 14, 2011 | Issued |
Array
(
[id] => 9009164
[patent_doc_number] => 08524460
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-03
[patent_title] => 'PSCA: prostate stem cell antigen and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/083205
[patent_app_country] => US
[patent_app_date] => 2011-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 90
[patent_no_of_words] => 46787
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13083205
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/083205 | PSCA: prostate stem cell antigen and uses thereof | Apr 7, 2011 | Issued |
Array
(
[id] => 10831048
[patent_doc_number] => 08859213
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-14
[patent_title] => 'Method for diagnosing melanocytic proliferations'
[patent_app_type] => utility
[patent_app_number] => 13/642475
[patent_app_country] => US
[patent_app_date] => 2011-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 12416
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642475
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/642475 | Method for diagnosing melanocytic proliferations | Apr 5, 2011 | Issued |
Array
(
[id] => 7696226
[patent_doc_number] => 20110230364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'METHODS FOR IDENTIFYING MODULATORS OF APOPTOSIS'
[patent_app_type] => utility
[patent_app_number] => 13/053169
[patent_app_country] => US
[patent_app_date] => 2011-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 27558
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230364.pdf
[firstpage_image] =>[orig_patent_app_number] => 13053169
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/053169 | METHODS FOR IDENTIFYING MODULATORS OF APOPTOSIS | Mar 20, 2011 | Abandoned |
Array
(
[id] => 9762002
[patent_doc_number] => 08846322
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-30
[patent_title] => 'Method and kit for isolating target cell'
[patent_app_type] => utility
[patent_app_number] => 13/582931
[patent_app_country] => US
[patent_app_date] => 2011-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 15
[patent_no_of_words] => 8737
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 237
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582931
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/582931 | Method and kit for isolating target cell | Mar 6, 2011 | Issued |
Array
(
[id] => 6175873
[patent_doc_number] => 20110177528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'METHODS FOR DETECTING AND INHIBITING ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 13/034415
[patent_app_country] => US
[patent_app_date] => 2011-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14650
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20110177528.pdf
[firstpage_image] =>[orig_patent_app_number] => 13034415
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/034415 | METHODS FOR DETECTING AND INHIBITING ANGIOGENESIS | Feb 23, 2011 | Abandoned |
Array
(
[id] => 6101625
[patent_doc_number] => 20110165117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'IMMUNOGENIC PEPTIDES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/025094
[patent_app_country] => US
[patent_app_date] => 2011-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 27539
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20110165117.pdf
[firstpage_image] =>[orig_patent_app_number] => 13025094
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/025094 | Immunogenic peptides and methods of use | Feb 9, 2011 | Issued |
Array
(
[id] => 6111222
[patent_doc_number] => 20110189693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'Methods for Cancer Diagnosis, Anti-Cancer Drug Screening, and Test of Drug Effectiveness on the Basis of Phoshorylation of Ras at Thr-144 and Thr-148'
[patent_app_type] => utility
[patent_app_number] => 13/019270
[patent_app_country] => US
[patent_app_date] => 2011-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5848
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20110189693.pdf
[firstpage_image] =>[orig_patent_app_number] => 13019270
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/019270 | Methods for Cancer Diagnosis, Anti-Cancer Drug Screening, and Test of Drug Effectiveness on the Basis of Phoshorylation of Ras at Thr-144 and Thr-148 | Jan 31, 2011 | Abandoned |
Array
(
[id] => 8607140
[patent_doc_number] => 20130012452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'METHOD FOR TREATING BRAIN CANCER USING A NOVEL TUMOR SUPPRESSOR GENE AND SECRETED FACTOR'
[patent_app_type] => utility
[patent_app_number] => 13/575289
[patent_app_country] => US
[patent_app_date] => 2011-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 13748
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575289
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/575289 | Method for treating brain cancer using a novel tumor suppressor gene and secreted factor | Jan 26, 2011 | Issued |